3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Melanoma
2
Endometrial Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Multiple Myeloma
1
Moderate Hepatic Impairment
1
Meningioma
1
Lymphoma
1
Lung Neoplasms
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Chondrosarcoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Carcinoma, Endometrioid
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
11
Rituximab
10
Prednisone
8
Lenalidomide
8
Vincristine
7
Doxorubicin
7
Bendamustine Hydrochloride
6
obinutuzumab
5
Magnetic Resonance Spectroscopy
4
fludarabine
3
Whole-Body Irradiation
3
Specimen Handling
3
R-CHOP protocol
3
Cyclosporine
3
Biopsy
3
zanubrutinib
2
fludarabine phosphate
2
Radiotherapy
2
Prednisolone
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Mycophenolic Acid
2
Melphalan
2
Gemcitabine
2
Etoposide
2
Cytarabine
2
venetoclax
1
umbralisib
1
treosulfan
1
tazemetostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
capivasertib
×
30 days
×
Clear all
No trials found.